Position
Chief Medical Officer
Company
Repertoire Immune Medicines
CambridgeBiotechnologyHealth CareTherapeuticsDescription
Repertoire Immune Medicines announces the appointment of Dr. Robert Andtbacka as Chief Medical Officer. Dr Andtbacka brings over 20 years of experience in oncology drug development, which will be invaluable as the company transitions to a clinical-stage organization.
Quick answer
Repertoire Immune Medicines Appoints Robert Andtbacka as Chief Medical Officer (June 4, 2025). Repertoire Immune Medicines is based in Cambridge, Massachusetts, United States.
- Who is the new Chief Medical Officer at Repertoire Immune Medicines?
- Repertoire Immune Medicines named Robert Andtbacka Chief Medical Officer, announced June 4, 2025.
- What did Repertoire Immune Medicines announce on June 4, 2025?
- Repertoire Immune Medicines announces the appointment of Dr. Robert Andtbacka as Chief Medical Officer. Dr Andtbacka brings over 20 years of experience in oncology drug development, which will be invaluable as the company transitions to a clinical-stage organization.
- What does Repertoire Immune Medicines do?
- Repertoire Immune Medicines is a biotechnology company pioneering the discovery and development of programmable T cell-targeted immune medicines.
- Where is Repertoire Immune Medicines based?
- Repertoire Immune Medicines is based in Cambridge, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Lobe Sciences (June 3, 2025), Elite Clinical Network (ECN) (June 2, 2025), Catalyst Pharmaceuticals (June 2, 2025) and Abcuro (June 9, 2025) also announced leadership changes within 45 days of Repertoire Immune Medicines.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Lobe Sciences Ltd. Appoints Yong Yao as Chief Financial Officer (June 3, 2025)
- Elite Clinical Network Appoints Christopher Brennan as Chief Executive Officer (June 2, 2025)
- Catalyst Pharmaceuticals Appoints Will T. Andrews as Chief Medical Officer (June 2, 2025)
- Abcuro Appoints Courtney Cupples as Chief Commercial Officer (June 9, 2025)
- RxMP Therapeutics Appoints Shawna Khouri as Chief Operating Officer (June 9, 2025)
- FibroBiologics Appoints Jason D. Davis as Chief Financial Officer (June 9, 2025)
Who to call at Repertoire Immune Medicines, and when
A new leader at Repertoire Immune Medicines brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Repertoire Immune Medicines raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Repertoire Immune Medicines, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Repertoire Immune Medicines. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Repertoire Immune Medicines changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Repertoire Immune Medicines changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.